Holen Sie sich die Stockscreener-App
25.45
0.43%
-0.11
Handel nachbörslich:
25.45
Xoma Corporation Aktie (XOMAO) Neueste Nachrichten
Can XOMA Royalty Corporation stock double in next 5 yearsWeekly Trade Review & Free Risk Controlled Daily Trade Plans - Улправда
Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced By Investing.com - Investing.com South Africa
Generation Bio is latest Mass. biotech to be acquired by Xoma - The Business Journals
XOMA to buy struggling Generation Bio - The Pharma Letter
Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced - Investing.com Nigeria
‘Zombie’ biotech buyer Xoma to acquire Generation Bio - Yahoo Finance
XOMA Strikes Deal To Acquire Generation Bio, Expanding Royalty Portfolio - Nasdaq
XOMA Royalty to Acquire Generation Bio - citybiz
Generation Bio Announces Merger with XOMA Royalty - TipRanks
Xoma Royalty enters into agreement to acquire Generation Bio - marketscreener.com
XOMA Royalty Corporation to Acquire Generation Bio Co. in Cash Transaction with Milestone and Royalty Opportunities - Quiver Quantitative
Generation Bio (NASDAQ: GBIO) agrees to $4.29 sale to XOMA Royalty plus CVR - Stock Titan
Investors Don't See Light At End Of XOMA Royalty Corporation's (NASDAQ:XOMA) Tunnel - simplywall.st
Generation Bio (GBIO) to be acquired in planned XOMA tender offer - Stock Titan
FY2025 EPS Estimates for XOMA Royalty Reduced by Analyst - MarketBeat
XOMA Royalty Corporation: A Deep Dive into a Biotech Royalty Aggregator (12/13/2025) - Markets Financial Content
BVF Inc. IL Has $65.28 Million Stock Position in XOMA Royalty Corporation $XOMA - MarketBeat
Why (XOMAO) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Price-Driven Insight from (XOMA) for Rule-Based Strategy - news.stocktradersdaily.com
XOMA stock maintains Buy rating at Benchmark despite partner’s trial setback - Investing.com
XOMA: HC Wainwright Maintains Buy Rating, Lowers Price Target to $97 | XOMA Stock News - GuruFocus
Leerink Partners lowers XOMA stock price target on RZ358 trial failure By Investing.com - Investing.com South Africa
HC Wainwright & Co. Maintains XOMA Royalty (XOMA) Buy Recommendation - Nasdaq
HC Wainwright & Co. Maintains XOMA Royalty CorporationPreferred Stock (XOMAP) Buy Recommendation - Nasdaq
Why two Bay Area companies' stocks tumbled on a drug's clinical failure - The Business Journals
XOMA stock price target lowered to $97 by H.C. Wainwright - Investing.com Australia
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Rating of "Hold" from Brokerages - MarketBeat
XOMA: Leerink Partners Lowers Price Target, Reiterates Outperfor - GuruFocus
Why Is XOMA Royalty Stock Sinking Thursday? - Benzinga
Leerink Partners lowers XOMA stock price target on RZ358 trial failure - Investing.com
LUCID CAPITAL MARKETS Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq
LUCID CAPITAL MARKETS Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq
Lucid Capital Markets initiates coverage on XOMA stock with Buy rating - Investing.com Canada
XOMA Royalty (XOMA): New Buy Rating Initiated by Lucid Capital M - GuruFocus
Xoma initiated with a Buy at Lucid Capital - TipRanks
CEO’s Bold Move: Massive Investment in Xoma Stock! - TipRanks
Insider Buying: XOMA Royalty (NASDAQ:XOMA) CEO Acquires 100,000 Shares of Stock - MarketBeat
XOMA Royalty Corp CEO Owen Hughes Acquires 100,000 Depositary Shares - TradingView
Xoma Royalty Expands Portfolio Through Mural Oncology Acquisition - AD HOC NEWS
XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share - Investing.com Nigeria
XOMA Royalty completes acquisition of Mural Oncology By Investing.com - Investing.com Nigeria
Xoma Completes Acquisition of Mural Oncology - TipRanks
Xoma announces closing of transaction to acquire Mural Oncology - TipRanks
XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share By Investing.com - Investing.com South Africa
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition - Research Tree
Xoma Royalty announces closing of transaction to acquire Mural Oncology plc - marketscreener.com
XOMA Royalty Corporation Completes Acquisition of Mural Oncology plc Under Irish High Court Sanctioned Scheme - Quiver Quantitative
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - The Manila Times
XOMA Royalty (Nasdaq: XOMA) completes $2.035 per share Mural Oncology takeover - Stock Titan
XOMA Royalty completes acquisition of Mural Oncology - Investing.com India
Mural Oncology plc Announces Effective Date of Scheme Arrangement for Acquisition by XOMA Royalty Corporation - Quiver Quantitative
0.31%
0.33%
Kapitalisierung:
|
Volumen (24h):